Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
The Ministry of Health and USAID's LHSS Project launches the Continuing Professional Development Online Training Platform in Jordan, providing health care professionals with accredited courses for certification and relicensing.
This report presents findings from December 2022 assessment of medical-grade liquid oxygen capabilities and availability for use in health facilities in the Kyrgyz Republic.
This brief presents work completed under the LHSS Kyrgyz Republic Activity Intervention 4: Enhance Cold Chain System. LHSS worked with key government stakeholders, including the Republican Center of Immunoprophylaxis, to digitalize and update components of the country’s vaccine registry and complement these updates by adding additional functionalities for cold chain tracking and management.
This fact sheet provides a summary of activity progress in Central Asia as well as results and impact.
Qaqish B, Sallam M, Al-Khateeb M, Reisdorf E, Mahafzah A. Assessment of COVID-19 Molecular Testing Capacity in Jordan: A Cross-Sectional Study at the Country Level. Diagnostics. 2022; 12(4):909. https://doi.org/10.3390/diagnostics12040909
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.
HMED software will improve Vietnam’s capacity to effectively forecast ARV demand, and manage the drugs when they are in the country. Also, engaging drug manufacturers and distributors is crucial to overcoming supply side obstacles.